Neximmune Inc logo

Neximmune Inc Share Price (NASDAQ: NEXI)

$0.05

Last updated on

Bell Icon

This instrument is not available for trading on the INDmoney app on 22 Aug 2024

Check the interactive Neximmune Inc Stock chart to analyse performance

Neximmune Inc Key Stats

Check Neximmune Inc key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$0.05
Open
$0.92
Market Capitalization
$1.5M
Today's Volume
$492.0
Revenue TTM
$0.0
EBITDA
$-21.2M
Earnings Per Share (EPS)
$-24.11
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-196.48%

Global Institutional Holdings in Neximmune Inc

  • Name

    Holdings %

  • Sabby Management LLC

    4.37%

  • Slate Path Capital LP

    2.70%

  • EPIQ Capital Group, LLC

    1.14%

  • PNC Financial Services Group Inc

    0.92%

  • Vanguard Group Inc

    0.88%

  • Raymond James & Associates

    0.79%

Analyst Recommendation on Neximmune Inc Stock

Rating
Trend

Buy

    85%Buy

    14%Hold

    0%Sell

Based on 7 Wall street analysts offering stock ratings for Neximmune Inc(by analysts ranked 0 to 5 stars)

About Neximmune Inc

NexImmune, Inc., a clinical-stage biotechnology company, engages in developing therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases in the United States. It develops approaches to T cell immunotherapies based on its proprietary Artificial Immune Modulation, a nanoparticle technology platform. The company's product candidates include NEXI-001, an allogeneic cell therapy, which is in Phase I/II clinical trials for the treatment of patients with acute myeloid leukemia; NEXI-002, an autologous cell therapy that is in Phase I/II clinical trials for the treatment of patients with relapsed and/or refractory in multiple myeloma; and NEXI-003, a product candidate targeted against HPV related cancers, which is in Phase I/II clinical trials. It provides NEXI-004 which is in preclinical stage for EBV related diseases; and NEXI005 designs for patient with specific targets for solid tumors. NexImmune, Inc. was incorporated in 2011 and is headquartered in Gaithersburg, Maryland.
Organization
Neximmune Inc
Employees
6
CEO
Ms. Kristi Jones R.Ph.
Industry
Miscellaneous

Important FAQs about investing in NEXI Stock from India :

What is Neximmune Inc share price today?

Neximmune Inc share price today is $0.05 as on at the close of the market. Neximmune Inc share today touched a day high of {{1_rba_end}} and a low of {{1_rba_st}}.

What is the 52 week high and 52 week low for Neximmune Inc share?

Neximmune Inc share touched a 52 week high of {{rba_end}} and a 52 week low of {{rba_st}}. Neximmune Inc stock price today i.e. is closed at $0.05, lower by 99.29% versus the 52 week high.

How to invest in Neximmune Inc Stock (NEXI) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Neximmune Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Neximmune Inc Shares that will get you 30.0000 shares as per Neximmune Inc share price of $0.05 per share as on August 22, 2024 at 12:00 am IST.

What is the minimum amount required to buy Neximmune Inc Stock (NEXI) from India?

Indian investors can start investing in Neximmune Inc (NEXI) shares with as little as ₹93.0575 or $1 (as of April 07, 2026) using the INDmoney app.
For example: If you want to invest $10 or ₹930.58 in Neximmune Inc stock (as per the Rupee-Dollar exchange rate as on April 07, 2026). Based on Neximmune Inc share’s latest price of $0.05 as on August 22, 2024 at 12:00 am IST, you will get 200.0000 shares of Neximmune Inc. Learn more about fractional shares .

What are the returns that Neximmune Inc has given to Indian investors in the last 5 years?

Neximmune Inc stock has given 0.0% share price returns and 26.63% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?